Cutaneous Melanoma: Sun Protection Behaviors and UV Exposure in Canada | Docwire News
A troubling rise in sun exposure and inconsistent sunscreen use may be linked to incidence of skin cancer in Canada.
Related Articles
Treatment Effects on Acute and Chronic GFR Slope in Clinical Trials | Docwire News
An analysis of chronic kidney disease (CKD) trials supported 3-year total slope as the primary slope-based outcome in randomized trials.
Targeting IDH1 Mutations: Olutasidenib Trial Begins in Higher-Risk MDS Patients | Docwire News
The study will assess the overall response to olutasidenib plus azacitidine in higher-risk MDS, CMML, and advanced MPNs.
Researchers Identify Environmental Risk Factors for IgAN and MN | Docwire News
Several genetically predicted environmental factors increase the risk of IgA nephropathy (IgAN) and membranous nephropathy (MN), a study found.
Minimizing Glucocorticoid Use in Patients With ANCA-Associated Vasculitis | Docwire News
A study found that combination cyclophosphamide and rituximab therapy for severe ANCA-associated vasculitis to minimize glucocorticoid use may reduce morbidity.
Iron Deficiency Anemia Correlated With Increased Likelihood of Ischemic Stroke | Docwire News
Iron deficiency anemia was associated with 39% increased odds of stroke, independent of the risk factors for stroke.
Proteinuria Trajectory Predicts Progression of IgA Nephropathy | Docwire News
Proteinuria trajectory is a major predictor of disease progression in children and adults with IgA nephropathy (IgAN), a study found.
Combo Therapy That Slashes UACR Could Be a Game Changer for CKD | Docwire News
Rajiv Agarwal, MBBS, discussed a study showing that a finerenone and empagliflozin combination has superior efficacy at reducing UACR in chronic kidney disease and type…
Enhanced Belimumab Results in BLISS-LN Subgroup Analysis | Docwire News
Dr. Richard Furie spoke with Nephrology Times about new data from the BLISS-LN study supporting the efficacy and safety of belimumab for active proliferative lupus…
Study Identifies microRNA-483-5p as Potential Biomarker for IgAN Progression | Docwire News
Research identified microRNA-483-5p as a possible biomarker for IgA nephropathy (IgAN) to help with risk stratification.